Oral Chemotherapy in the Treatment of Hormone-Refractory Prostate Cancer

被引：0
作者：
Kenneth J. Pienta
Jeffrey M. Kamradt
David C. Smith
机构：
[1] The University of Michigan School of Medicine,The University of Michigan Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Internal Medicine
来源：
Drugs | 1999年 / 58卷
关键词：
Prostate Cancer; Paclitaxel; Adis International Limited; Etoposide; Nuclear Matrix;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Oral chemotherapy has become a major component of the treatment of advanced prostate cancer. The recognition that prostate cancer grows very slowly and must be treated continuously with active agents has led to the development of several therapeutic regimens. These regimens employ oral agents such as estramustine, cyclophosphamide, and etoposide, as they can be taken on a daily basis at home by the patients. These regimens have demonstrated activity in patients with hormone-refractory prostate cancer; declines in both prostate specific antigen and soft tissue lesions have been demonstrated.
引用
收藏
页码：127 / 131
页数：4
相关论文
共 84 条
[1]  
Parker SL(1997)Cancer statistics, 1997 CA Cancer J Clin 47 5-27
[2]  
Tong T(1995)Implication of cell kinetic changes during the progression of human prostatic cancer Clin Can Res 1 473-80
[3]  
Bolden S(1982)Hormonally responsive Cancer Res 42 5010-4
[4]  
Berges RR(1988) unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat prostatic adenocarcinomas NCI Monogr 7 151-63
[5]  
Vukanovic J(1984)Chemotherapy for prostate carcinoma Urology 23 54-63
[6]  
Epstein JI(1986)Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial Institute Prostate 9 387-95
[7]  
Isaacs JT(1986)Nuclear protein matrix as a target for estramustine-induced cell death Annu Rev Biophys Biophys Chem 15 457-75
[8]  
Eisenberger MA(1983)The role of the nuclear matrix in the organization and function of DNA Nature 306 607-9
[9]  
Murphy GP(1994)Actively transcribed genes are associated with the nuclear matrix Cancer 74 100-3
[10]  
Slack NH(1986)Oral etoposide in the treatment of hormone-refractory prostate cancer Cancer Treat Rep 70 771-2
123456789